TFE3 alleviates hepatic steatosis through autophagy-induced lipophagy and PGC1α-mediated fatty acid β-oxidation

International Journal of Molecular Sciences

Volumn 17, Issue 3, 2016, Pages

  Xiong, Jie ^a   Wang, Kezhou ^b   He, Jiangping ^a   Zhang, Guangya ^a   Zhang, Dandan ^a   Chen, Fengling ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Hepatic steatosis; PGC1 ; TFE3; oxidation

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E3; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; PPARGC1A PROTEIN, HUMAN; TFE3 PROTEIN, HUMAN;

ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BIOCHEMICAL ANALYSIS; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID OXIDATION; FATTY LIVER; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIPID METABOLISM; LIPOPHAGOCYTOSIS; LUCIFERASE ASSAY; METABOLIC FLUX ANALYSIS; MITOCHONDRIAL RESPIRATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA PURIFICATION; WESTERN BLOTTING; LIVER CELL; METABOLISM; SIGNAL TRANSDUCTION;

AUTOPHAGY; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; FATTY ACIDS; FATTY LIVER; HEPATOCYTES; HUMANS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; SIGNAL TRANSDUCTION;

EID: 84962563171     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17030387     Document Type: Article

References (33)

1. Brunt, E.M. Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation. Int. J. Mol. Sci. 2015, 17, 97[CrossRef] [PubMed]
2. Choi, S.S.; Diehl, A.M. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr. Opin. Lipidol. 2008, 19, 295–300[CrossRef] [PubMed]
3. Berlanga, A.; Guiu-Jurado, E.; Porras, J.A.; Auguet, T. Molecular pathways in non-alcoholic fatty liver disease. Clin. Exp. Gastroenterol. 2014, 7, 221–239[PubMed]
4. Martinet, W.; Agostinis, P.; Vanhoecke, B.; Dewaele, M.; de Meyer, G.R. Autophagy in disease: A double-edged sword with therapeutic potential. Clin. Sci. 2009, 116, 697–712[CrossRef] [PubMed]
5. Amir, M.; Czaja, M.J. Autophagy in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 2011, 5, 159–166[CrossRef] [PubMed]
6. Rubinsztein, D.C.; Codogno, P.; Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 2012, 11, 709–30[CrossRef] [PubMed]
7. Choi, A.M.; Ryter, S.W.; Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368, 1845–1846[CrossRef] [PubMed]
8. Singh, R.; Kaushik, S.; Wang, Y.; Xiang, Y.; Novak, I.; Komatsu, M.; Tanaka, K.; Cuervo, A.M.; Czaja, M.J. Autophagy regulates lipid metabolism. Nature 2009, 458, 1131–1135[CrossRef] [PubMed]
9. Koga, H.; Kaushik, S.; Cuervo, A.M. Altered lipid content inhibits autophagic vesicular fusion. FASEB J. 2010, 24, 3052–3065[CrossRef] [PubMed]
10. Yang, L.; Li, P.; Fu, S.; Calay, E.S.; Hotamisligil, G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010, 11, 467–478[CrossRef] [PubMed]
11. Inami, Y.; Yamashina, S.; Izumi, K.; Ueno, T.; Tanida, I.; Ikejima, K.; Watanabe, S. Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidification and cathepsin expression. Biochem. Biophys. Res. Commun. 2011, 412, 618–625[CrossRef] [PubMed]
12. Harada, M.; Hanada, S.; Toivola, D.M.; Ghori, N.; Omary, M.B. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation. Hepatology 2008, 47, 2026–2035[CrossRef] [PubMed]
13. Lin, C.W.; Zhang, H.; Li, M.; Xiong, X.; Chen, X.; Chen, X.; Dong, X.C.; Yin, X.M. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J. Hepatol. 2013, 58, 993–999[CrossRef] [PubMed]
14. Chen, R.; Wang, Q.; Song, S.; Liu, F.; He, B.; Gao, X. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice. Eur. J. Pharmacol. 2016, 770, 126–133[CrossRef] [PubMed]
15. Taniguchi, M.; Nadanaka, S.; Tanakura, S.; Sawaguchi, S.; Midori, S.; Kawai, Y.; Yamaguchi, S.; Shimada, Y.; Nakamura, Y.; Matsumura, Y.; et al. TFE3 is a bHLH-ZIP-type transcription factor that regulates the mammalian Golgi stress response. Cell Struct. Funct. 2015, 40, 13–30[CrossRef] [PubMed]
16. Martina, J.A.; Diab, H.I.; Lishu, L.; Jeong, A.L.; Patange, S.; Raben, N.; Puertollano, R. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci. Signal. 2014, 7, ra9[CrossRef] [PubMed]
17. Tasset, I.; Cuervo, A.M. Role of chaperone-mediated autophagy in metabolism. FEBS J. 2016[CrossRef] [PubMed]
18. Kabeya, Y.; Mizushima, N.; Yamamoto, A.; Oshitani-Okamoto, S.; Ohsumi, Y.; Yoshimori, T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004, 117, 2805–2812[CrossRef] [PubMed]
19. Skop, V.; Cahova, M.; Papackova, Z.; Palenickova, E.; Dankova, H.; Baranowski, M.; Zabielski, P.; Zdychova, J.; Zidkova, J.; Kazdova, L. Autophagy-lysosomal pathway is involved in lipid degradation in rat liver. Physiol. Res. 2012, 61, 287–297[PubMed]
20. Fukuo, Y.; Yamashina, S.; Sonoue, H.; Arakawa, A.; Nakadera, E.; Aoyama, T.; Uchiyama, A.; Kon, K.; Ikejima, K.; Watanabe, S. Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease. Hepatol. Res. 2014, 44, 1026–1036[CrossRef] [PubMed]
21. Lavallard, V.J.; Gual, P. Autophagy and non-alcoholic fatty liver disease. BioMed Res. Int. 2014, 2014, 120179
22. Martina, J.A.; Diab, H.I.; Li, H.; Puertollano, R. Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis. Cell. Mol. Life Sci. 2014, 71, 2483–2497[CrossRef] [PubMed]
23. Fuchs, M.; Sanyal, A.J. Lipotoxicity in NASH. J. Hepatol. 2012, 56, 291–293[CrossRef] [PubMed]
24. Valdecantos, M.P.; Prieto-Hontoria, P.L.; Pardo, V.; Modol, T.; Santamaria, B.; Weber, M.; Herrero, L.; Serra, D.; Muntane, J.; Cuadrado, A.; et al. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes. Free Radic. Biol. Med. 2015, 84, 263–278[CrossRef] [PubMed]
25. Yin, J.; Luo, Y.; Deng, H.; Qin, S.; Tang, W.; Zeng, L.; Zhou, B. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells. J. Ethnopharmacol. 2014, 154, 229–239[CrossRef] [PubMed]
26. Finck, B.N.; Kelly, D.P. PGC-1 coactivators: Inducible regulators of energy metabolism in health and disease. J. Clin. Investig. 2006, 116, 615–622[CrossRef] [PubMed]
27. Rolo, A.P.; Teodoro, J.S.; Palmeira, C.M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2012, 52, 59–69[CrossRef] [PubMed]
28. Ventura-Clapier, R.; Garnier, A.; Veksler, V. Transcriptional control of mitochondrial biogenesis: The central role of PGC-1α. Cardiovasc. Res. 2008, 79, 208–217[CrossRef] [PubMed]
29. Scarpulla, R.C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta Mol. Cell Res. 2011, 1813, 1269–1278[CrossRef] [PubMed]
30. Nakagawa, Y.; Shimano, H.; Yoshikawa, T.; Ide, T.; Tamura, M.; Furusawa, M.; Yamamoto, T.; Inoue, N.; Matsuzaka, T.; Takahashi, A.; et al. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat. Med. 2006, 12, 107–113[CrossRef] [PubMed]
31. Iwasaki, H.; Naka, A.; Iida, K.T.; Nakagawa, Y.; Matsuzaka, T.; Ishii, K.A.; Kobayashi, K.; Takahashi, A.; Yatoh, S.; Yahagi, N.; et al. TFE3 regulates muscle metabolic gene expression, increases glycogen stores, and enhances insulin sensitivity in mice. Am. J. Physiol. Endoc. Metab. 2012, 302, E896–E902[CrossRef] [PubMed]
32. Aksan, I.; Goding, C.R. Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol. Cell. Biol. 1998, 18, 6930–6938[CrossRef] [PubMed]
33. Sinha, R.A.; Farah, B.L.; Singh, B.K.; Siddique, M.M.; Li, Y.; Wu, Y.; Ilkayeva, O.R.; Gooding, J.; Ching, J.; Zhou, J.; et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology 2014, 59, 1366–1380[CrossRef] [PubMed]